Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Docetaxel, Capecitabine and Oxaliplatin (DXO) in Patients With Advanced Stomach Cancer

NCT00446290 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT00446290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Docetaxel, Capecitabine and Oxaliplatin (DXO) in Patients With Advanced Stomach Cancer
Lead sponsor
Asan Medical Center
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2006
Completion date
October 31, 2007
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach cancer